143 related articles for article (PubMed ID: 21976676)
1. Epigenetic inactivation of the MIR34B/C in multiple myeloma.
Wong KY; Yim RL; So CC; Jin DY; Liang R; Chim CS
Blood; 2011 Nov; 118(22):5901-4. PubMed ID: 21976676
[TBL] [Abstract][Full Text] [Related]
2. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of MIR203 in multiple myeloma.
Wong KY; Liang R; So CC; Jin DY; Costello JF; Chim CS
Br J Haematol; 2011 Sep; 154(5):569-78. PubMed ID: 21707582
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chim CS
J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
[TBL] [Abstract][Full Text] [Related]
5. Global epigenetic regulation of microRNAs in multiple myeloma.
Zhang W; Wang YE; Zhang Y; Leleu X; Reagan M; Zhang Y; Mishima Y; Glavey S; Manier S; Sacco A; Jiang B; Roccaro AM; Ghobrial IM
PLoS One; 2014; 9(10):e110973. PubMed ID: 25330074
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
Chim CS; Pang R; Fung TK; Choi CL; Liang R
Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
[TBL] [Abstract][Full Text] [Related]
8. Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma.
Nojima M; Maruyama R; Yasui H; Suzuki H; Maruyama Y; Tarasawa I; Sasaki Y; Asaoku H; Sakai H; Hayashi T; Mori M; Imai K; Tokino T; Ishida T; Toyota M; Shinomura Y
Clin Cancer Res; 2009 Jul; 15(13):4356-64. PubMed ID: 19549772
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
[TBL] [Abstract][Full Text] [Related]
13. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.
Wang LQ; Kumar S; Calin GA; Li Z; Chim CS
Br J Haematol; 2020 Jul; 190(2):249-261. PubMed ID: 32079038
[TBL] [Abstract][Full Text] [Related]
14. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of microRNA expression in Hodgkin lymphoma.
Navarro A; Díaz T; Cordeiro A; Beyá MD; Ferrer G; Fuster D; Martinez A; Monzó M
Leuk Lymphoma; 2015; 56(9):2683-9. PubMed ID: 25586608
[TBL] [Abstract][Full Text] [Related]
16. Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.
Kaiser MF; Johnson DC; Wu P; Walker BA; Brioli A; Mirabella F; Wardell CP; Melchor L; Davies FE; Morgan GJ
Blood; 2013 Jul; 122(2):219-26. PubMed ID: 23699600
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.
Wong KY; Li Z; Zhang X; Leung GK; Chan GC; Chim CS
Mol Cancer; 2015 Sep; 14():175. PubMed ID: 26410378
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
